ArticleThe Journal of experimental medicine2021

AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma.

Keitaro Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.